Email this article SRAVNITEL'NOE ISSLEDOVANIE SPETsIFIChESKOY AKTIVNOSTI ZhIVOY I INAKTIVIROVANNOY VAKTsIN PROTIV POTENTsIAL'NO PANDEMIChESKOGO GRIPPA NA MORSKIKh SVINKAKh
- Authors: Sergeeva MV1
-
Affiliations:
- НИИ гриппа
- Issue: Vol 12, No 4 (2012)
- Pages: 52-54
- Section: Articles
- URL: https://journal-vniispk.ru/MAJ/article/view/9952
- DOI: https://doi.org/10.17816/MAJ12452-54
- ID: 9952
Cite item
Open Access
Access granted
Subscription Access
Abstract
Full Text
##article.viewOnOriginalSite##References
- Cox R. J., Brokstad K. A., Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines // Scand. J. Immunol.- 2004.- Vol. 59.- P. 1-15.
- Александрова Г. И., Климов А. И. Живая вакцина против гриппа.- М.: Наука, 1994.
- Цыбалова Л. М., Горев Н. Е., Потапчук М. В. и др. Штамм вируса гриппа А/Гонконг/1/68/162/35(H3N2) как донор аттенуации и высокой репродуктивности // Вопр. вирусол.- 2012.- Т. 57, № 6.- (в печати).
- Tsybalova L. M., Gorev N.E., Repko 1.А. et al. Influenza strain A/HK/1/68/162/35 as potential unified vaccine donor // The Fourth ESWI Influenza Conference. 11-14 September 2011. Malta.- 2011.- Р. 129.
- WHO. Avian influenza in humans. [Электронный ресурс]. Режим доступа: http://www.who.int/influenza/human_animal_interface/ avian_influenza/en/ (дата обращения 30.07.2012).
- Chen L. M., Blixt O., Stevens J. et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity // Virology.-2012.- Vol. 422.- P. 105-113.
- Imai M., Watanabe T., Hatta M. et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets // Nature.- 2012.- Vol. 486.- P. 420-428.
- Lowen A.C., Steel J., Mubareka S. et al. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model // J. Virol.-2009.- Vol. 83.- P. 2803-2818.
- Kistner O., Howard M. K., Spruth M. et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses // Vaccine.- 2007.- Vol. 25.- P. 6028-6036.
- Van Hoeven N., Belser J.A., Szretter K. J. et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding // J. Virol.- 2009.- Vol. 83.- P. 2851-2861.
- Nurpeysova A., Khairullin B., Kassenov M. et al. Preclinical testing of Kazfluvac, a vaccine against pandemic influenza A/H5N1v // J. Pharm. Biomed. Sci.- 2011.- Vol. 1.- P. 108-112.
Supplementary files
